EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities

Litong Wu, Junfeng Qiu, Zhiming Hong, Quan Wang, Qixin Li, Wenbin Zhou

Frontiers in Cell and Developmental Biology · 14.11.2025 · 13

DOI: 10.3389/fcell.2025.1685857 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 14.11.2025. Verfasst von Litong Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer, ranking among the most prevalent malignancies in males worldwide, is undergoing a significant evolution in therapeutic paradigms from conventional approaches to precision medicine, with recent advances in targeted therapies offering novel strategic insights. This review delineates the molecular foundations of prostate carcinogenesis, elucidating pivotal domains including genetic mutations, hormonal regulation, tumor microenvironment dynamics, cell cycle dysregulation, epigenetic modifications, and tumor heterogeneity. Furthermore, we evaluate the clinical translation of targeted strategies such as AR signaling axis inhibition, PI3K/AKT/mTOR pathway modulation, DNA damage repair machinery exploitation, prostate-specific membrane antigen -directed interventions, and combinatorial immunotherapy. Concurrent challenges—AR-driven heterogeneity, adaptive drug resistance mechanisms, spliceosomal vulnerabilities, and scarcity of selective molecular targets—are critically analyzed. Notwithstanding these obstacles, targeted therapies exhibit considerable potential to enhance therapeutic efficacy while mitigating systemic toxicities, paving the way for more personalized and precision-oriented oncologic care. By underscoring the imperative to decode prostate cancer’s molecular architecture, this work outlines future research priorities and advances a robust scientific framework for innovation in therapeutic development.

Schlagwörter

Stichwörter der Autor:innen

PROTACsandrogen receptormolecular mechanismsprostate cancertargeted therapytumor microenvironment

Autor:innen und Institutionen

  • Andrology Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
  • The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China.
  • Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Shenzhen, China.

Zitieren

APA

Wu, L., Qiu, J., Hong, Z., Wang, Q., Li, Q., & Zhou, W. (2025). Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1685857

Vancouver

Wu L, Qiu J, Hong Z, Wang Q, Li Q, Zhou W. Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1685857

BibTeX
@article{Wu2025,
  author = {Wu, Litong and Qiu, Junfeng and Hong, Zhiming and Wang, Quan and Li, Qixin and Zhou, Wenbin},
  title = {Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1685857}
}
Kostenlos starten →